Research ArticleArticle
Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study
Dan Nordström, Ann Knight, Reijo Luukkainen, Ronald van Vollenhoven, Vappu Rantalaiho, Anna Kajalainen, Johan G. Brun, Anne Proven, Lotta Ljung, Hannu Kautiainen and Tom Pettersson
The Journal of Rheumatology August 2012, jrheum.111549; DOI: https://doi.org/10.3899/jrheum.111549
Dan Nordström
Ann Knight
Reijo Luukkainen
Ronald van Vollenhoven
Vappu Rantalaiho
Anna Kajalainen
Johan G. Brun
Anne Proven
Lotta Ljung
Hannu Kautiainen
In this issue
The Journal of Rheumatology
Vol. 48, Issue 3
1 Mar 2021
Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study
Dan Nordström, Ann Knight, Reijo Luukkainen, Ronald van Vollenhoven, Vappu Rantalaiho, Anna Kajalainen, Johan G. Brun, Anne Proven, Lotta Ljung, Hannu Kautiainen, Tom Pettersson
The Journal of Rheumatology Aug 2012, jrheum.111549; DOI: 10.3899/jrheum.111549
Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study
Dan Nordström, Ann Knight, Reijo Luukkainen, Ronald van Vollenhoven, Vappu Rantalaiho, Anna Kajalainen, Johan G. Brun, Anne Proven, Lotta Ljung, Hannu Kautiainen, Tom Pettersson
The Journal of Rheumatology Aug 2012, jrheum.111549; DOI: 10.3899/jrheum.111549